Medicare Enrolled

Dr. Jose Fune, MD

Infectious Disease · Neptune, NJ
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
19 DAVIS AVE FL 6, Neptune, NJ 07753
7328973995
In practice since 2006 (20 years)
NPI: 1043289184 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Fune from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fune? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Fune

Dr. Jose Fune is an infectious disease specialist in Neptune, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Fune performed 1,720 Medicare services across 1,148 unique beneficiaries.

Between the years covered by Open Payments, Dr. Fune received a total of $7,920 from 58 pharmaceutical and/or device companies across 320 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in infectious disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Fune is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 38% volume in NJ $7,920 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,720
Medicare services
Top 38% in NJ for infectious disease
1,148
Unique beneficiaries
$84
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~86 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
615 $66 $241
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
456 $145 $623
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
439 $42 $145
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
86 $86 $434
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
52 $62 $307
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
39 $140 $564
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
33 $100 $345
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,920
Total received (2018-2024)
Avg $1,131/year across 7 years
Top 13% in NJ for infectious disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
320
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,473 (94.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$326 (4.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$121 (1.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$714
2023
$557
2022
$1,535
2021
$1,535
2020
$764
2019
$2,008
2018
$806

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$156
Shionogi Inc
$148
Theratechnologies Inc.
$137
Gilead Sciences, Inc.
$104
ViiV Healthcare Company
$64
Merck Sharp & Dohme LLC
$46
Aurinia Pharma U.S., Inc.
$17
Dexcom, Inc.
$16
SOBI, INC
$14
AIMMUNE THERAPEUTICS, INC.
$13
Top 3 companies account for 61.7% of 2024 payments
All-time payments by company (2018-2024) ›
Gilead Sciences, Inc.
$922
Boehringer Ingelheim Pharmaceuticals, Inc.
$742
ViiV Healthcare Company
$663
AbbVie, Inc.
$412
AbbVie Inc.
$380
ABBVIE INC.
$367
Esperion Therapeutics, Inc.
$343
Merck Sharp & Dohme Corporation
$341
Insmed, Inc.
$336
Shionogi Inc
$333
Theratechnologies Inc.
$252
Allergan, Inc.
$240
Janssen Biotech, Inc.
$230
Astellas Pharma US Inc
$223
Merck Sharp & Dohme LLC
$169
Amarin Pharma Inc.
$125
bioMerieux Inc
$121
Acerta Pharma LLC
$114
GlaxoSmithKline, LLC.
$113
AstraZeneca Pharmaceuticals LP
$112
E.R. Squibb & Sons, L.L.C.
$110
Novartis Pharmaceuticals Corporation
$102
Lilly USA, LLC
$95
Allergan Inc.
$85
Mylan Pharmaceuticals Inc.
$79
Novo Nordisk Inc
$76
Dynavax Technologies Corporation
$66
PFIZER INC.
$60
Amgen Inc.
$57
Melinta Therapeutics, Inc.
$57
Melinta Therapeutics, LLC
$44
Radius Health, Inc.
$40
Theravance Biopharma, Inc.
$40
bioMerieux
$34
Cumberland Pharmaceuticals, Inc.
$29
Ferring Pharmaceuticals Inc.
$28
Embecta Corp.
$28
PORTOLA PHARMACEUTICALS, INC.
$27
Napo Pharmaceuticals Inc
$27
Janssen Products, LP
$25
TETRAPHASE PHARMACEUTICALS, INC.
$23
Oxford Immunotec USA Inc
$22
Aurinia Pharma U.S., Inc.
$17
Dexcom, Inc.
$16
Becton, Dickinson and Company
$15
Corcept Therapeutics
$15
Alexion Pharmaceuticals, Inc.
$15
Otsuka America Pharmaceutical, Inc.
$15
Clarus Therapeutics Inc.
$15
Amryt Pharma Holdings Ltd
$14
SANOFI PASTEUR INC.
$14
SOBI, INC
$14
MannKind Corporation
$14
UCB, Inc.
$14
Vyera Pharmaceuticals, LLC
$14
AIMMUNE THERAPEUTICS, INC.
$13
Mannkind Corporation
$13
SANOFI-AVENTIS U.S. LLC
$13
Top 3 companies account for 29.4% of all-time payments
Associated products mentioned in payments ›
AFREZZA · APRETUDE · AVYCAZ · Arikayce · BD Nano 2nd Gen Pen Needle · BEVYXXA · Biktarvy · CABENUVA · COSENTYX · CRESEMBA · Cimzia · DALVANCE · DIFICID · DOVATO · Daraprim Tablet 25mg · Dexcom G6 Transmitter · EGRIFTA · EGRIFTA SV · ELIQUIS · Enbrel · Epclusa · FARXIGA · FLUBLOK QUADRIVALENT · FORTEO · Fetroja · HUMIRA · HUMULIN · Heplisav-B · Humira · ISENTRESS · JANUVIA · JARDIANCE · JATENZO · JULUCA · KINERET · Korlym · LUPKYNIS · MAVYRET · MYCAPSSA · Mavyret · Mytesi · NEPHROCHECK · NEXLIZET · Orbactiv · Ozempic · PAXLOVID · PIFELTRO · PNEUMOVAX 23 · PRADAXA · PREVNAR 20 · PREVYMIS · PREZCOBIX · PREZISTA · REBYOTA · RINVOQ · Rezzayo · Rinvoq · SAMSCA · SHINGRIX · SPIRIVA · STIOLTO · SYMTUZA · Strensiq · Symfi Lo · TALTZ · TEFLARO · TOUJEO · TRELEGY ELLIPTA · TRIUMEQ · TROGARZO · TSPOT TB TEST · Tavneos · Tymlos · VIBATIV · VOWST · Vabomere · Vascepa · Vibativ · XERAVA · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an infectious disease specialist in Neptune?
Compare infectious diseases in the Neptune area by procedure volume, costs, and industry payment transparency.
Browse infectious diseases nearby

Geographic Context

Infectious diseases within 10 mi
40
Per 100K population
6.2
County median income
$122,727
Nearest hospital
MONMOUTH MEDICAL CENTER
7.4 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Fune is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 13% of NJ peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Fune experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Fune performed 615 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Fune receive payments from pharmaceutical companies?
Yes. Dr. Fune received a total of $7,920 from 58 companies across 320 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fune's costs compare to other infectious diseases in Neptune?
Dr. Fune's average Medicare payment per service is $84. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fune) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →